{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:35:12Z","timestamp":1777494912939,"version":"3.51.4"},"publisher-location":"Cham","reference-count":215,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030731182","type":"print"},{"value":"9783030731199","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-73119-9_7","type":"book-chapter","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T03:35:59Z","timestamp":1634614559000},"page":"123-152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Dog as a Model to Study the Tumor Microenvironment"],"prefix":"10.1007","author":[{"given":"Maria I.","family":"Carvalho","sequence":"first","affiliation":[]},{"given":"Teresa P.","family":"Raposo","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Silva-Carvalho","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Pires","sequence":"additional","affiliation":[]},{"given":"Justina","family":"Prada","sequence":"additional","affiliation":[]},{"given":"Hugo","family":"Greg\u00f3rio","sequence":"additional","affiliation":[]},{"given":"Felisbina L.","family":"Queiroga","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"7_CR1","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.3892\/or.2016.4660","volume":"35","author":"Y Yuan","year":"2016","unstructured":"Yuan Y, Jiang YC, Sun CK, Chen QM (2016) Role of the tumor microenvironment in tumor progression and the clinical applications (review). Oncol Rep 35:2499\u20132515","journal-title":"Oncol Rep"},{"key":"7_CR2","doi-asserted-by":"publisher","unstructured":"Finn OJ (2012) Immuno-oncology: understanding the function and dysfunction of the immune system in cancer. https:\/\/doi.org\/10.1093\/annonc\/mds256","DOI":"10.1093\/annonc\/mds256"},{"key":"7_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10555-010-9223-6","volume":"29","author":"DG DeNardo","year":"2010","unstructured":"DeNardo DG, Andreu P, Coussens LM (2010) Interactions between lymphocytes and myeloid cells regulate pro-versus anti-tumor immunity. Cancer Metastasis Rev 29:309\u2013316","journal-title":"Cancer Metastasis Rev"},{"key":"7_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1677\/erc.1.01185","volume":"13","author":"N Normanno","year":"2006","unstructured":"Normanno N, Gullick WJ (2006) Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: different mechanisms of action for a novel therapeutic application? Endocr Relat Cancer 13:3\u20136","journal-title":"Endocr Relat Cancer"},{"key":"7_CR5","doi-asserted-by":"publisher","unstructured":"Estrela-Lima A, Ara\u00fajo MSS, Costa-Neto JM et al (2010) Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates. BMC Cancer 10. https:\/\/doi.org\/10.1186\/1471-2407-10-256","DOI":"10.1186\/1471-2407-10-256"},{"key":"7_CR6","first-page":"2915","volume":"35","author":"MI Carvalho","year":"2015","unstructured":"Carvalho MI, Pires I, Prada J et al (2015) Positive interplay between CD3+ T-lymphocytes and concurrent COX-2\/EGFR expression in canine malignant mammary tumors. Anticancer Res 35:2915\u20132920","journal-title":"Anticancer Res"},{"key":"7_CR7","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/CMR.0000000000000262","volume":"26","author":"H Greg\u00f3rio","year":"2016","unstructured":"Greg\u00f3rio H, Raposo TP, Queiroga FL et al (2016) Investigating associations of cyclooxygenase-2 expression with angiogenesis, proliferation, macrophage and T-lymphocyte infiltration in canine melanocytic tumours. Melanoma Res 26:338\u2013347. https:\/\/doi.org\/10.1097\/CMR.0000000000000262","journal-title":"Melanoma Res"},{"key":"7_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1439-0531.2012.02135.x","volume":"48","author":"JH Kim","year":"2013","unstructured":"Kim JH, Chon SK, Im KS et al (2013) Infiltrating Foxp3+ Regulatory T cells and histopathological features in canine classical and spermatocytic seminomas. Reprod Domest Anim 48:218\u2013222. https:\/\/doi.org\/10.1111\/j.1439-0531.2012.02135.x","journal-title":"Reprod Domest Anim"},{"key":"7_CR9","doi-asserted-by":"publisher","first-page":"920409","DOI":"10.1155\/2015\/920409","volume":"2015","author":"MI Carvalho","year":"2015","unstructured":"Carvalho MI, Pires I, Dias M et al (2015) Intratumoral CD3+ T-lymphocytes immunoexpression and its association with c-Kit, angiogenesis, and overall survival in malignant canine mammary tumors. Anal Cell Pathol (Amst) 2015:920409. https:\/\/doi.org\/10.1155\/2015\/920409","journal-title":"Anal Cell Pathol (Amst)"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1476-5829.2012.00326.x","volume":"12","author":"T Raposo","year":"2014","unstructured":"Raposo T, Greg\u00f3rio H, Pires I et al (2014) Prognostic value of tumour-associated macrophages in canine mammary tumours. Vet Comp Oncol 12:10\u201319. https:\/\/doi.org\/10.1111\/j.1476-5829.2012.00326.x","journal-title":"Vet Comp Oncol"},{"key":"7_CR11","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/path.4218","volume":"230","author":"SYC Choi","year":"2013","unstructured":"Choi SYC, Collins CC, Gout PW, Wang Y (2013) Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite? J Pathol 230:350\u2013355","journal-title":"J Pathol"},{"key":"7_CR12","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of Cancer: The Next Generation. Cell 144:646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nrneph.2017.59","volume":"13","author":"HI Wettersten","year":"2017","unstructured":"Wettersten HI, Aboud OA, Lara PN, Weiss RH (2017) Metabolic reprogramming in clear cell renal cell carcinoma. Nat Rev Nephrol 13:410\u2013419","journal-title":"Nat Rev Nephrol"},{"key":"7_CR14","doi-asserted-by":"publisher","unstructured":"L\u00f3pez de la Oliva AR, Campos-Sandoval JA, G\u00f3mez-Garc\u00eda MC et al (2020) Nuclear translocation of Glutaminase GLS2 in human cancer cells associates with proliferation arrest and differentiation. Sci Rep 10. https:\/\/doi.org\/10.1038\/s41598-020-58264-4","DOI":"10.1038\/s41598-020-58264-4"},{"key":"7_CR15","doi-asserted-by":"publisher","unstructured":"Harting TP, Stubbendorff M, Hammer SC et al (2017) Dichloroacetate affects proliferation but not apoptosis in canine mammary cell lines. PLoS One 12. https:\/\/doi.org\/10.1371\/journal.pone.0178744","DOI":"10.1371\/journal.pone.0178744"},{"key":"7_CR16","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.3892\/ijo.2016.3720","volume":"49","author":"T Harting","year":"2016","unstructured":"Harting T, Stubbendorff M, Willenbrock S et al (2016) The effect of dichloroacetate in canine prostate adenocarcinomas and transitional cell carcinomas in vitro. Int J Oncol 49:2341\u20132350. https:\/\/doi.org\/10.3892\/ijo.2016.3720","journal-title":"Int J Oncol"},{"key":"7_CR17","doi-asserted-by":"publisher","unstructured":"Burrai GP, Tanca A, Cubeddu T et al (2017) A first immunohistochemistry study of transketolase and transketolase-like 1 expression in canine hyperplastic and neoplastic mammary lesions. BMC Vet Res 13. https:\/\/doi.org\/10.1186\/s12917-017-0961-3","DOI":"10.1186\/s12917-017-0961-3"},{"key":"7_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.canlet.2015.07.039","volume":"368","author":"L Hui","year":"2015","unstructured":"Hui L, Chen Y (2015) Tumor microenvironment: sanctuary of the devil. Cancer Lett 368:7\u201313. https:\/\/doi.org\/10.1016\/j.canlet.2015.07.039","journal-title":"Cancer Lett"},{"key":"7_CR19","doi-asserted-by":"publisher","unstructured":"Brassart-Pasco S, Brezilon S, Brassart B et al (2020) Tumor microenvironment: extracellular matrix alterations influence tumor progression. Front Oncol 10. https:\/\/doi.org\/10.3389\/fonc.2020.00397","DOI":"10.3389\/fonc.2020.00397"},{"key":"7_CR20","doi-asserted-by":"publisher","unstructured":"dos Reis DC, Damasceno KA, de Campos CB et al (2019) Versican and tumor-associated macrophages promotes tumor progression and metastasis in canine and murine models of breast carcinoma. Front Oncol 9. https:\/\/doi.org\/10.3389\/fonc.2019.00577","DOI":"10.3389\/fonc.2019.00577"},{"key":"7_CR21","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/vco.12223","volume":"15","author":"LH Pulz","year":"2017","unstructured":"Pulz LH, Strefezzi RF (2017) Proteases as prognostic markers in human and canine cancers. Vet Comp Oncol 15:669\u2013683. https:\/\/doi.org\/10.1111\/vco.12223","journal-title":"Vet Comp Oncol"},{"key":"7_CR22","doi-asserted-by":"publisher","unstructured":"Brachelente C, Cappeli K, Capommacio S et al (2017) Transcriptome analysis of canine cutaneous melanoma and melanocytoma reveals a modulation of genes regulating extracellular matrix metabolism and cell cycle. Sci Rep 7. https:\/\/doi.org\/10.1038\/s41598-017-06281-1","DOI":"10.1038\/s41598-017-06281-1"},{"key":"7_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen X, Song E (2019) Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov 18:99\u2013115. https:\/\/doi.org\/10.1038\/s41573-018-0004-1","journal-title":"Nat Rev Drug Discov"},{"key":"7_CR24","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","volume":"24","author":"D Lambrechts","year":"2018","unstructured":"Lambrechts D, Wauters E, Boeckx B et al (2018) Phenotype molding of stromal cells in the lung tumor microenvironment. Nat Med 24:1277\u20131289. https:\/\/doi.org\/10.1038\/s41591-018-0096-5","journal-title":"Nat Med"},{"key":"7_CR25","doi-asserted-by":"publisher","unstructured":"Liu T, Han C, Wang S et al (2019) Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy. J Hematol Oncol 12. https:\/\/doi.org\/10.1186\/s13045-019-0770-1","DOI":"10.1186\/s13045-019-0770-1"},{"key":"7_CR26","doi-asserted-by":"publisher","unstructured":"Poltavets V, Kochetkova M, Pitson S et al (2018) The role of the extracellular matrix and its molecular and cellular regulators in cancer cell plasticity. Front Oncol 8. https:\/\/doi.org\/10.3389\/fonc.2018.00431","DOI":"10.3389\/fonc.2018.00431"},{"key":"7_CR27","doi-asserted-by":"publisher","unstructured":"Kr\u00f3l M, Pawlowski K, Szyszko K et al (2012) The gene expression profiles of canine mammary cancer cells grown with carcinoma-associated fibroblasts (CAFs) as a co-culture in vitro. BMC Vet Res 8. https:\/\/doi.org\/10.1186\/1746-6148-8-35","DOI":"10.1186\/1746-6148-8-35"},{"key":"7_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.21873\/invivo.11763","volume":"34","author":"P Borecka","year":"2020","unstructured":"Borecka P, Ciaputa R, Janus I et al (2020) Expression of podoplanin in mammary cancers in female dogs. In Vivo International Institute of Anticancer Research 34:213\u2013223. https:\/\/doi.org\/10.21873\/invivo.11763","journal-title":"In Vivo International Institute of Anticancer Research"},{"key":"7_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1089\/mab.2016.0036","volume":"35","author":"MK Kaneko","year":"2016","unstructured":"Kaneko MK, Honma R, Ogasawara S et al (2016) PMab-38 recognizes canine podoplanin of squamous cell carcinomas. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 35:263\u2013266. https:\/\/doi.org\/10.1089\/mab.2016.0036","journal-title":"Monoclonal Antibodies in Immunodiagnosis and Immunotherapy"},{"key":"7_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1089\/mab.2016.0040","volume":"35","author":"S Ogasawara","year":"2016","unstructured":"Ogasawara S, Honma R, Kaneko M et al (2016) Podoplanin expression in canine melanoma monoclonal antibodies in immunodiagnosis and immunotherapy. Monoclon Antib Immunodiagn Immunother 35:304\u2013306. https:\/\/doi.org\/10.1089\/mab.2016.0040","journal-title":"Monoclon Antib Immunodiagn Immunother"},{"key":"7_CR31","doi-asserted-by":"publisher","unstructured":"Pulz LH, Barra C, Alexandre P et al (2019) Identification of two molecular subtypes in canine mast cell tumours through gene expression profiling. PLoS One 14. https:\/\/doi.org\/10.1371\/journal.pone.0217343","DOI":"10.1371\/journal.pone.0217343"},{"key":"7_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3727\/096368910X532837","volume":"20","author":"S-Y Chen","year":"2011","unstructured":"Chen S-Y, Huang Y-C, Liu S-P et al (2011) An overview of concepts for cancer stem cells. Cell Transplant 20:113\u2013120. https:\/\/doi.org\/10.3727\/096368910X532837","journal-title":"Cell Transplant"},{"key":"7_CR33","doi-asserted-by":"crossref","unstructured":"Rybicka A, Kr\u00f3l M (2016) Identification and characterization of cancer stem cells in canine mammary tumors. Acta Vet Scand 58","DOI":"10.1186\/s13028-016-0268-6"},{"key":"7_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1177\/0300985818813653","volume":"56","author":"B Rogez","year":"2019","unstructured":"Rogez B, Pascal Q, Bobillier A et al (2019) CD44 and CD24 expression and prognostic significance in canine mammary tumors. Vet Pathol 56:377\u2013388. https:\/\/doi.org\/10.1177\/0300985818813653","journal-title":"Vet Pathol"},{"key":"7_CR35","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1387\/ijdb.113363mf","volume":"55","author":"M Ferletta","year":"2011","unstructured":"Ferletta M, Graw\u00e9 J, Hellm\u00e9n E (2011) Canine mammary tumors contain cancer stem-like cells and form spheroids with an embryonic stem cell signature. Int J Dev Biol 55:791\u2013799. https:\/\/doi.org\/10.1387\/ijdb.113363mf","journal-title":"Int J Dev Biol"},{"key":"7_CR36","unstructured":"Zhu Z, Zhu X, Yang S et al (2020) Yin-yang effect of tumour cells in breast cancer: from mechanism of crosstalk between tumour-associated macrophages and cancer-associated adipocytes. Am J Cancer Res 10:383\u2013392"},{"key":"7_CR37","doi-asserted-by":"publisher","unstructured":"Liu L, Wu Y, Zhang C et al (2020) Cancer-associated adipocytes-derived G-CSF promotes breast cancer malignancy via Stat3 signaling. J Mol Cell Biol. https:\/\/doi.org\/10.1093\/jmcb\/mjaa016","DOI":"10.1093\/jmcb\/mjaa016"},{"key":"7_CR38","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1177\/0300985815579994","volume":"52","author":"HY Lim","year":"2015","unstructured":"Lim HY, Im KS, Kim NH et al (2015) Effects of obesity and obesity-related molecules on canine mammary gland tumors. Vet Pathol 52:1045\u20131051. https:\/\/doi.org\/10.1177\/0300985815579994","journal-title":"Vet Pathol"},{"key":"7_CR39","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.tvjl.2015.01.005","volume":"203","author":"HY Lim","year":"2015","unstructured":"Lim HY, Im KS, Kim NH et al (2015) Obesity, expression of adipocytokines, and macrophage infiltration in canine mammary tumors. Vet J 203:326\u2013331. https:\/\/doi.org\/10.1016\/j.tvjl.2015.01.005","journal-title":"Vet J"},{"key":"7_CR40","doi-asserted-by":"publisher","unstructured":"Carvalho MI, Pires I, Prada J et al (2016) High COX-2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: A multivariate survival study. Vet Comp Oncol. https:\/\/doi.org\/10.1111\/vco.12206","DOI":"10.1111\/vco.12206"},{"key":"7_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vetimm.2016.06.006","volume":"178","author":"MI Carvalho","year":"2016","unstructured":"Carvalho MI, Pires I, Prada J et al (2016) Intratumoral FoxP3 expression is associated with angiogenesis and prognosis in malignant canine mammary tumors. Vet Immunol Immunopathol 178:1\u20139. https:\/\/doi.org\/10.1016\/j.vetimm.2016.06.006","journal-title":"Vet Immunol Immunopathol"},{"key":"7_CR42","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/vco.12067","volume":"13","author":"TP Raposo","year":"2015","unstructured":"Raposo TP, Pires I, Carvalho MI et al (2015) Tumour-associated macrophages are associated with vascular endothelial growth factor expression in canine mammary tumours. Vet Comp Oncol 13:464\u2013474. https:\/\/doi.org\/10.1111\/vco.12067","journal-title":"Vet Comp Oncol"},{"key":"7_CR43","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jcpa.2013.09.006","volume":"150","author":"N Sleeckx","year":"2014","unstructured":"Sleeckx N, Van Brantegem L, Van den Eynden G et al (2014) Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study. J Comp Pathol 150:184\u2013193. https:\/\/doi.org\/10.1016\/j.jcpa.2013.09.006","journal-title":"J Comp Pathol"},{"key":"7_CR44","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1177\/0300985813503568","volume":"51","author":"L Camacho","year":"2014","unstructured":"Camacho L, Pe\u00f1a L, Gil AG et al (2014) Immunohistochemical vascular factor expression in canine inflammatory mammary carcinoma. Vet Pathol 51:737\u2013748. https:\/\/doi.org\/10.1177\/0300985813503568","journal-title":"Vet Pathol"},{"key":"7_CR45","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M (2010) Immunity, Inflammation, and Cancer. Cell 140:883\u2013899","journal-title":"Cell"},{"key":"7_CR46","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.tvjl.2015.04.015","volume":"205","author":"TP Raposo","year":"2015","unstructured":"Raposo TP, Beir\u00e3o BCB, Pang LY et al (2015) Inflammation and cancer: till death tears them apart. Vet J 205:161\u2013174. https:\/\/doi.org\/10.1016\/j.tvjl.2015.04.015","journal-title":"Vet J"},{"key":"7_CR47","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.3390\/ijms21103457","volume":"21","author":"N Mukaida","year":"2020","unstructured":"Mukaida N, Sasaki S, Baba T (2020) Two-faced roles of tumor-associated neutrophils in cancer development and progression. Int J Mol Sci 21:3457. https:\/\/doi.org\/10.3390\/ijms21103457","journal-title":"Int J Mol Sci"},{"key":"7_CR48","doi-asserted-by":"crossref","unstructured":"Snoderly HT, Boone BA, Bennewitz MF (2019) Neutrophil extracellular traps in breast cancer and beyond: current perspectives on NET stimuli, thrombosis and metastasis, and clinical utility for diagnosis and treatment. Breast Cancer Res 21:145","DOI":"10.1186\/s13058-019-1237-6"},{"key":"7_CR49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/0300985819861721","volume":"57","author":"R Goggs","year":"2020","unstructured":"Goggs R, Jeffery U, LeVine DN, Li RHL (2020) Neutrophil-extracellular traps, cell-free DNA, and immunothrombosis in companion animals: a review. Vet Pathol 57:6\u201323","journal-title":"Vet Pathol"},{"key":"7_CR50","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/jsap.12435","volume":"57","author":"L Macfarlane","year":"2016","unstructured":"Macfarlane L, Morris J, Pratschke K et al (2016) Diagnostic value of neutrophil-lymphocyte and albumin-globulin ratios in canine soft tissue sarcoma. J Small Anim Pract 57:135\u2013141. https:\/\/doi.org\/10.1111\/jsap.12435","journal-title":"J Small Anim Pract"},{"key":"7_CR51","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1136\/vr.103650","volume":"179","author":"MJ MacFarlane","year":"2016","unstructured":"MacFarlane MJ, MacFarlane LL, Scase T et al (2016) Use of neutrophil to lymphocyte ratio for predicting histopathological grade of canine mast cell tumours. Vet Rec 179:491. https:\/\/doi.org\/10.1136\/vr.103650","journal-title":"Vet Rec"},{"key":"7_CR52","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.rvsc.2018.06.012","volume":"119","author":"TA de Souza","year":"2018","unstructured":"de Souza TA, de Campos CB, De Biasi Bassani Gon\u00e7alves A et al (2018) Relationship between the inflammatory tumor microenvironment and different histologic types of canine mammary tumors. Res Vet Sci 119:209\u2013214. https:\/\/doi.org\/10.1016\/j.rvsc.2018.06.012","journal-title":"Res Vet Sci"},{"key":"7_CR53","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/cmi.2017.35","volume":"14","author":"A Sarvaria","year":"2017","unstructured":"Sarvaria A, Madrigal JA, Saudemont A (2017) B cell regulation in cancer and anti-tumor immunity. Cell Mol Immunol 14:662\u2013674","journal-title":"Cell Mol Immunol"},{"key":"7_CR54","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.intimp.2018.12.007","volume":"67","author":"X Cai","year":"2019","unstructured":"Cai X, Zhang L, Wei W (2019) Regulatory B cells in inflammatory diseases and tumor. Int Immunopharmacol 67:281\u2013286","journal-title":"Int Immunopharmacol"},{"key":"7_CR55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ctrv.2018.12.001","volume":"73","author":"R Tokunaga","year":"2019","unstructured":"Tokunaga R, Naseem M, Lo JH et al (2019) B cell and B cell-related pathways for novel cancer treatments. Cancer Treat Rev 73:10\u201319","journal-title":"Cancer Treat Rev"},{"key":"7_CR56","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1158\/1078-0432.CCR-18-1481","volume":"24","author":"MCA Wouters","year":"2018","unstructured":"Wouters MCA, Nelson BH (2018) Prognostic significance of tumor-infiltrating B cells and plasma cells in human cancer. Clin Cancer Res 24:6125\u20136135","journal-title":"Clin Cancer Res"},{"key":"7_CR57","doi-asserted-by":"publisher","unstructured":"Porcellato I, Silvestri S, Menchetti L et al (2019) Tumour-infiltrating lymphocytes in canine melanocytic tumours: an investigation on the prognostic role of CD3+ and CD20+ lymphocytic populations. Vet Comp Oncol. https:\/\/doi.org\/10.1111\/vco.12556","DOI":"10.1111\/vco.12556"},{"key":"7_CR58","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1158\/2159-8290.CD-18-1398","volume":"9","author":"S Faulkner","year":"2019","unstructured":"Faulkner S, Jobling P, March B et al (2019) Tumor neurobiology and the war of nerves in cancer. Cancer Discov 9:702\u2013710","journal-title":"Cancer Discov"},{"key":"7_CR59","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1016\/j.ajpath.2014.08.009","volume":"184","author":"J Pundavela","year":"2014","unstructured":"Pundavela J, Demont Y, Jobling P et al (2014) ProNGF correlates with Gleason score and is a potential driver of nerve infiltration in prostate cancer. Am J Pathol 184:3156\u20133162. https:\/\/doi.org\/10.1016\/j.ajpath.2014.08.009","journal-title":"Am J Pathol"},{"key":"7_CR60","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1158\/0008-5472.CAN-14-3180","volume":"75","author":"P Jobling","year":"2015","unstructured":"Jobling P, Pundavela J, Oliveira SMR et al (2015) Nerve-cancer cell cross-talk: a novel promoter of tumor progression. Cancer Res 75:1777\u20131781","journal-title":"Cancer Res"},{"key":"7_CR61","unstructured":"Prazeres PHDM, Leonel C, Silva WN et al (2020) Ablation of sensory nerves favours melanoma progression. J Cell Mol Med:1\u201313"},{"key":"7_CR62","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57\u201370","journal-title":"Cell"},{"key":"7_CR63","unstructured":"Carvalho MI, Pires I, Prada J, Queiroga FL T-lymphocytic infiltrate in canine mammary tumours: clinic and prognostic implications. In Vivo 25:963\u2013969"},{"key":"7_CR64","doi-asserted-by":"publisher","unstructured":"Greg\u00f3rio H, Raposo T, Queiroga FL et al (2016) High COX-2 expression in canine mast cell tumours is associated with proliferation, angiogenesis and decreased overall survival. Vet Comp Oncol. https:\/\/doi.org\/10.1111\/vco.12280","DOI":"10.1111\/vco.12280"},{"key":"7_CR65","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322.Inflammation","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Coussens L M, Werb Z. Inflammation and cancer [J]. Pharmaceutical Biotechnology, 2002, 420(6917)860. Nature 420:860\u2013867. https:\/\/doi.org\/10.1038\/nature01322.Inflammation","journal-title":"Nature"},{"key":"7_CR66","doi-asserted-by":"crossref","unstructured":"Waris G, Ahsan H (2006) Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog 5:14","DOI":"10.1186\/1477-3163-5-14"},{"key":"7_CR67","doi-asserted-by":"publisher","first-page":"387014","DOI":"10.1155\/2013\/387014","volume":"2013","author":"S Ohnishi","year":"2013","unstructured":"Ohnishi S, Ma N, Thanan R et al (2013) DNA damage in inflammation-related carcinogenesis and cancer stem cells. Oxidative Med Cell Longev 2013:387014. https:\/\/doi.org\/10.1155\/2013\/387014","journal-title":"Oxidative Med Cell Longev"},{"key":"7_CR68","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1073\/pnas.1612920114","volume":"114","author":"V Prima","year":"2017","unstructured":"Prima V, Kaliberova LN, Kaliberov S et al (2017) COX2\/mPGES1\/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells. Proc Natl Acad Sci U S A 114:1117\u20131122. https:\/\/doi.org\/10.1073\/pnas.1612920114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR69","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/vco.12197","volume":"15","author":"G Hartley","year":"2017","unstructured":"Hartley G, Faulhaber E, Caldwell A et al (2017) Immune regulation of canine tumour and macrophage PD-L1 expression. Vet Comp Oncol 15:534\u2013549. https:\/\/doi.org\/10.1111\/vco.12197","journal-title":"Vet Comp Oncol"},{"key":"7_CR70","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/vco.12209","volume":"15","author":"TP Raposo","year":"2017","unstructured":"Raposo TP, Pires I, Prada J et al (2017) Exploring new biomarkers in the tumour microenvironment of canine inflammatory mammary tumours. Vet Comp Oncol 15:655\u2013666. https:\/\/doi.org\/10.1111\/vco.12209","journal-title":"Vet Comp Oncol"},{"key":"7_CR71","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1600-065X.2008.00607.x","volume":"222","author":"P Allavena","year":"2008","unstructured":"Allavena P, Sica A, Garlanda C, Mantovani A (2008) The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev 222:155\u2013161","journal-title":"Immunol Rev"},{"key":"7_CR72","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccr.2005.02.013","volume":"7","author":"F Balkwill","year":"2005","unstructured":"Balkwill F, Charles KA, Mantovani A (2005) Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7:211\u2013217","journal-title":"Cancer Cell"},{"key":"7_CR73","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.humimm.2009.02.008","volume":"70","author":"A Mantovani","year":"2009","unstructured":"Mantovani A, Sica A, Allavena P et al (2009) Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Hum Immunol 70:325\u2013330. https:\/\/doi.org\/10.1016\/j.humimm.2009.02.008","journal-title":"Hum Immunol"},{"key":"7_CR74","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1189\/jlb.1107762","volume":"84","author":"JW Pollard","year":"2008","unstructured":"Pollard JW (2008) Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol 84:623\u2013630. https:\/\/doi.org\/10.1189\/jlb.1107762","journal-title":"J Leukoc Biol"},{"key":"7_CR75","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.1158\/0008-5472.CAN-10-1439","volume":"70","author":"AL Doedens","year":"2010","unstructured":"Doedens AL, Stockmann C, Rubinstein MP et al (2010) Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res 70:7465\u20137475. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-1439","journal-title":"Cancer Res"},{"key":"7_CR76","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/bjc.1995.419","volume":"72","author":"R Hildenbrand","year":"1995","unstructured":"Hildenbrand R, Dilger I, H\u00f6rlin A, Stutte HJ (1995) Urokinase and macrophages in tumour angiogenesis. Br J Cancer 72:818\u2013823. https:\/\/doi.org\/10.1038\/bjc.1995.419","journal-title":"Br J Cancer"},{"key":"7_CR77","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1189\/jlb.1105656","volume":"80","author":"C Lamagna","year":"2006","unstructured":"Lamagna C, Aurrand-Lions M, Imhof BA (2006) Dual role of macrophages in tumor growth and angiogenesis. J Leukoc Biol 80:705\u2013713. https:\/\/doi.org\/10.1189\/jlb.1105656","journal-title":"J Leukoc Biol"},{"key":"7_CR78","first-page":"4625","volume":"56","author":"RD Leek","year":"1996","unstructured":"Leek RD, Lewis CE, Whitehouse R et al (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56:4625\u20134629","journal-title":"Cancer Res"},{"key":"7_CR79","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1158\/0008-5472.CAN-05-4005","volume":"66","author":"CE Lewis","year":"2006","unstructured":"Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66:605\u2013612","journal-title":"Cancer Res"},{"key":"7_CR80","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray PJ, Allen JE, Biswas SK et al (2014) Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41:14\u201320","journal-title":"Immunity"},{"key":"7_CR81","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10456-013-9381-6","volume":"17","author":"N Jetten","year":"2014","unstructured":"Jetten N, Verbruggen S, Gijbels MJ et al (2014) Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis 17:109\u2013118. https:\/\/doi.org\/10.1007\/s10456-013-9381-6","journal-title":"Angiogenesis"},{"key":"7_CR82","doi-asserted-by":"publisher","unstructured":"Beir\u00e3o BCB, Raposo T, Pang LY, Argyle DJ (2015) Canine mammary cancer cells direct macrophages toward an intermediate activation state between M1\/M2. BMC Vet Res 11. https:\/\/doi.org\/10.1186\/s12917-015-0473-y","DOI":"10.1186\/s12917-015-0473-y"},{"key":"7_CR83","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO;2-F","volume":"82","author":"V Goede","year":"1999","unstructured":"Goede V, Brogelli L, Ziche M, Augustin HG (1999) Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer 82:765\u2013770. https:\/\/doi.org\/10.1002\/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO;2-F","journal-title":"Int J Cancer"},{"key":"7_CR84","first-page":"4681","volume":"59","author":"G Luboshits","year":"1999","unstructured":"Luboshits G, Shina S, Kaplan O et al (1999) Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res 59:4681\u20134687","journal-title":"Cancer Res"},{"key":"7_CR85","first-page":"3282","volume":"6","author":"T Ueno","year":"2000","unstructured":"Ueno T, Toi M, Saji H et al (2000) Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 6:3282\u20133289","journal-title":"Clin Cancer Res"},{"key":"7_CR86","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/hp.s50269","volume":"2","author":"S Walmsley","year":"2014","unstructured":"Walmsley S, Harris A, Thompson AAR, Whyte MKB (2014) HIF-mediated innate immune responses: cell signaling and therapeutic implications. Hypoxia 2:47. https:\/\/doi.org\/10.2147\/hp.s50269","journal-title":"Hypoxia"},{"key":"7_CR87","doi-asserted-by":"publisher","first-page":"109973","DOI":"10.1016\/j.vetimm.2019.109973","volume":"219","author":"SM Park","year":"2020","unstructured":"Park SM, Li Q, Ryu MO et al (2020) Preconditioning of canine adipose tissue-derived mesenchymal stem cells with deferoxamine potentiates anti-inflammatory effects by directing\/reprogramming M2 macrophage polarization. Vet Immunol Immunopathol 219:109973. https:\/\/doi.org\/10.1016\/j.vetimm.2019.109973","journal-title":"Vet Immunol Immunopathol"},{"key":"7_CR88","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1158\/0008-5472.CAN-06-1823","volume":"67","author":"JB Wyckoff","year":"2007","unstructured":"Wyckoff JB, Wang Y, Lin EY et al (2007) Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 67:2649\u20132656. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-1823","journal-title":"Cancer Res"},{"key":"7_CR89","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/ncb3371","volume":"18","author":"C Baer","year":"2016","unstructured":"Baer C, Squadrito ML, Laoui D et al (2016) Suppression of microRNA activity amplifies IFN-\u03b3-induced macrophage activation and promotes anti-tumour immunity. Nat Cell Biol 18:790\u2013802. https:\/\/doi.org\/10.1038\/ncb3371","journal-title":"Nat Cell Biol"},{"key":"7_CR90","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10753-010-9226-z","volume":"34","author":"CC Lee","year":"2011","unstructured":"Lee CC, Liu KJ, Wu YC et al (2011) Sesamin inhibits macrophage-induced vascular endothelial growth factor and matrix metalloproteinase-9 expression and proangiogenic activity in breast cancer cells. Inflammation 34:209\u2013221. https:\/\/doi.org\/10.1007\/s10753-010-9226-z","journal-title":"Inflammation"},{"key":"7_CR91","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1172\/JCI27648","volume":"116","author":"Y Luo","year":"2006","unstructured":"Luo Y, Zhou H, Krueger J et al (2006) Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest 116:2132\u20132141. https:\/\/doi.org\/10.1172\/JCI27648","journal-title":"J Clin Invest"},{"key":"7_CR92","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A et al (2017) Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 14:399\u2013416. https:\/\/doi.org\/10.1038\/nrclinonc.2016.217","journal-title":"Nat Rev Clin Oncol"},{"key":"7_CR93","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/sj.bjc.6603240","volume":"95","author":"SM Zeisberger","year":"2007","unstructured":"Zeisberger SM, Odermatt B, Marty C et al (2007) Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer 95:272\u2013281","journal-title":"Br J Cancer"},{"key":"7_CR94","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/bjc.2013.93","volume":"108","author":"ZG Fridlender","year":"2013","unstructured":"Fridlender ZG, Jassar A, Mishalian I et al (2013) Using macrophage activation to augment immunotherapy of established tumours. Br J Cancer 108:1288\u20131297. https:\/\/doi.org\/10.1038\/bjc.2013.93","journal-title":"Br J Cancer"},{"key":"7_CR95","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.tvjl.2016.11.005","volume":"218","author":"BCB Beir\u00e3o","year":"2016","unstructured":"Beir\u00e3o BCB, Raposo T, Jain S et al (2016) Challenges and opportunities for monoclonal antibody therapy in veterinary oncology. Vet J 218:40\u201350","journal-title":"Vet J"},{"key":"7_CR96","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2478\/v10181-011-0001-3","volume":"14","author":"M Kr\u00f3l","year":"2011","unstructured":"Kr\u00f3l M, Paw\u0142owski KM, Majchrzak K et al (2011) Density of tumor-associated macrophages (TAMs) and expression of their growth factor receptor MCSF-R and CD14 in canine mammary adenocarcinomas of various grade of malignancy and metastasis. Pol J Vet Sci 14:3\u201310. https:\/\/doi.org\/10.2478\/v10181-011-0001-3","journal-title":"Pol J Vet Sci"},{"key":"7_CR97","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/vco.12206","volume":"15","author":"MI Carvalho","year":"2017","unstructured":"Carvalho MI, Pires I, Prada J et al (2017) High COX-2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: a multivariate survival study. Vet Comp Oncol 15:619\u2013631. https:\/\/doi.org\/10.1111\/vco.12206","journal-title":"Vet Comp Oncol"},{"key":"7_CR98","first-page":"491","volume":"67","author":"A Rybicka","year":"2016","unstructured":"Rybicka A, Eylieten C, Taciak B et al (2016) Tumour-associated macrophages influence canine mammary cancer stem-like cells enhancing their pro-angiogenic properties. PubMed \u2013 NCBI J Physiol Pharmacol 67:491\u2013500","journal-title":"PubMed \u2013 NCBI J Physiol Pharmacol"},{"key":"7_CR99","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.rvsc.2019.08.021","volume":"126","author":"MS Franzoni","year":"2019","unstructured":"Franzoni MS, Brandi A, de Oliveira Matos Prado JK et al (2019) Tumor-infiltrating CD4+ and CD8+ lymphocytes and macrophages are associated with prognostic factors in triple-negative canine mammary complex type carcinoma. Res Vet Sci 126:29\u201336. https:\/\/doi.org\/10.1016\/j.rvsc.2019.08.021","journal-title":"Res Vet Sci"},{"key":"7_CR100","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.tvjl.2018.02.016","volume":"234","author":"LN Monteiro","year":"2018","unstructured":"Monteiro LN, Rodrigues MA, Gomes DA et al (2018) Tumour-associated macrophages: relation with progression and invasiveness, and assessment of M1\/M2 macrophages in canine mammary tumours. Vet J 234:119\u2013125. https:\/\/doi.org\/10.1016\/j.tvjl.2018.02.016","journal-title":"Vet J"},{"key":"7_CR101","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1177\/0300985817750457","volume":"55","author":"BJ Seung","year":"2018","unstructured":"Seung BJ, Lim HY, Shin J Il, et al. (2018) CD204-expressing tumor-associated macrophages are associated with malignant, high-grade, and hormone receptor\u2013negative canine mammary gland tumors. Vet Pathol 55:417\u2013424. https:\/\/doi.org\/10.1177\/0300985817750457","journal-title":"Vet Pathol"},{"key":"7_CR102","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.21873\/anticanres.12525","volume":"38","author":"MI Carvalho","year":"2018","unstructured":"Carvalho MI, Bianchini R, Fazekas-Singer J et al (2018) Bidirectional regulation of COX-2 expression between cancer cells and macrophages. Anticancer Res 38:2811\u20132817. https:\/\/doi.org\/10.21873\/anticanres.12525","journal-title":"Anticancer Res"},{"key":"7_CR103","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.cmet.2019.07.015","volume":"30","author":"P Bieniasz-Krzywiec","year":"2019","unstructured":"Bieniasz-Krzywiec P, Mart\u00edn-P\u00e9rez R, Ehling M et al (2019) Podoplanin-expressing macrophages promote lymphangiogenesis and lymphoinvasion in breast cancer. Cell Metab 30:917\u2013936.e10. https:\/\/doi.org\/10.1016\/j.cmet.2019.07.015","journal-title":"Cell Metab"},{"key":"7_CR104","doi-asserted-by":"publisher","first-page":"39190","DOI":"10.1038\/srep39190","volume":"6","author":"SG Allen","year":"2016","unstructured":"Allen SG, Chen YC, Madden JM et al (2016) Macrophages enhance migration in inflammatory breast cancer cells via RhoC GTPase signaling. Sci Rep 6:39190. https:\/\/doi.org\/10.1038\/srep39190","journal-title":"Sci Rep"},{"key":"7_CR105","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3892\/or.14.2.425","volume":"14","author":"S Tsutsui","year":"2005","unstructured":"Tsutsui S, Yasuda K, Suzuki K et al (2005) Macrophage infiltration and its prognostic implications in breast cancer: The relationship with VEGF expression and microvessel density. Oncol Rep 14:425\u2013431. https:\/\/doi.org\/10.3892\/or.14.2.425","journal-title":"Oncol Rep"},{"key":"7_CR106","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4048\/jbc.2019.22.e5","volume":"22","author":"H Jeong","year":"2019","unstructured":"Jeong H, Hwang I, Kang SH et al (2019) Tumor-associated macrophages as potential prognostic biomarkers of invasive breast cancer. J Breast Cancer 22:38\u201351. https:\/\/doi.org\/10.4048\/jbc.2019.22.e5","journal-title":"J Breast Cancer"},{"key":"7_CR107","doi-asserted-by":"publisher","unstructured":"Silveira TL, Veloso ES, Gon\u00e7alves INN et al (2020) Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas. Vet Comp Oncol vco 12601. https:\/\/doi.org\/10.1111\/vco.12601","DOI":"10.1111\/vco.12601"},{"key":"7_CR108","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/CMR.0000000000000549","volume":"29","author":"WJ Lee","year":"2019","unstructured":"Lee WJ, Lee MH, Kim HT et al (2019) Prognostic significance of CD163 expression and its correlation with cyclooxygenase-2 and vascular endothelial growth factor expression in cutaneous melanoma. Melanoma Res 29:501\u2013509. https:\/\/doi.org\/10.1097\/CMR.0000000000000549","journal-title":"Melanoma Res"},{"key":"7_CR109","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.prostaglandins.2007.03.003","volume":"83","author":"F Bianchini","year":"2007","unstructured":"Bianchini F, Massi D, Marconi C et al (2007) Expression of cyclo-oxygenase-2 in macrophages associated with cutaneous melanoma at different stages of progression. Prostaglandins Other Lipid Mediat 83:320\u2013328. https:\/\/doi.org\/10.1016\/j.prostaglandins.2007.03.003","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"7_CR110","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/vco.12444","volume":"17","author":"SS Withers","year":"2019","unstructured":"Withers SS, Skorupski KA, York D et al (2019) Association of macrophage and lymphocyte infiltration with outcome in canine osteosarcoma. Vet Comp Oncol 17:49\u201360. https:\/\/doi.org\/10.1111\/vco.12444","journal-title":"Vet Comp Oncol"},{"key":"7_CR111","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1331193","volume":"6","author":"A Gomez-Brouchet","year":"2017","unstructured":"Gomez-Brouchet A, Illac C, Gilhodes J et al (2017) CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: an immunohistochemical analysis of the biopsies from the French OS2006 phase 3 trial. Onco Targets Ther 6:e1331193. https:\/\/doi.org\/10.1080\/2162402X.2017.1331193","journal-title":"Onco Targets Ther"},{"key":"7_CR112","doi-asserted-by":"publisher","unstructured":"Woldemeskel M, Hawkins I, Whittington L (2017) Ki-67 protein expression and tumor associated inflammatory cells (macrophages and mast cells) in canine colorectal carcinoma. BMC Vet Res 13. https:\/\/doi.org\/10.1186\/s12917-017-1030-7","DOI":"10.1186\/s12917-017-1030-7"},{"key":"7_CR113","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/his.13674","volume":"73","author":"Y Kim","year":"2018","unstructured":"Kim Y, Wen X, Bae JM et al (2018) The distribution of intratumoral macrophages correlates with molecular phenotypes and impacts prognosis in colorectal carcinoma. Histopathology 73:663\u2013671. https:\/\/doi.org\/10.1111\/his.13674","journal-title":"Histopathology"},{"key":"7_CR114","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.humpath.2017.09.012","volume":"69","author":"K Wang","year":"2017","unstructured":"Wang K, Shen T, Siegal GP et al (2017) The CD4\/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer. Hum Pathol 69:110\u2013117. https:\/\/doi.org\/10.1016\/j.humpath.2017.09.012","journal-title":"Hum Pathol"},{"issue":"3","key":"7_CR115","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1245\/ASO.2004.05.027","volume":"11","author":"BA Pockaj","year":"2004","unstructured":"Pockaj BA, Basu GD, Pathangey et al (2004) Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer. Ann Surg Oncol 11(3):328\u2013339","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"7_CR116","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13058-017-0858-x","volume":"19","author":"G Zhang","year":"2017","unstructured":"Zhang G, Zhang W, Li B et al (2017) MicroRNA-200c and microRNA-141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer. Breast Cancer Res BCR 19(1):73. https:\/\/doi.org\/10.1186\/s13058-017-0858-x","journal-title":"Breast Cancer Res BCR"},{"key":"7_CR117","doi-asserted-by":"publisher","unstructured":"Maekawa N, Konnai S, Takagi S et al (2017) A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma. Sci Rep 7. https:\/\/doi.org\/10.1038\/s41598-017-09444-2","DOI":"10.1038\/s41598-017-09444-2"},{"issue":"10","key":"7_CR118","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/intimm\/dxm091","volume":"19","author":"RM Wong","year":"2007","unstructured":"Wong RM, Scotland RR, Lau RL et al (2007) Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs. Int Immunol 19(10):1223\u20131234. https:\/\/doi.org\/10.1093\/intimm\/dxm091","journal-title":"Int Immunol"},{"issue":"13","key":"7_CR119","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1158\/0008-5472.CAN-12-4115","volume":"73","author":"Y Mao","year":"2013","unstructured":"Mao Y, Poschke I, Wennerberg E et al (2013) Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms. Cancer Res 73(13):3877\u20133887. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-4115","journal-title":"Cancer Res"},{"issue":"3","key":"7_CR120","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/vco.12459","volume":"17","author":"SS Withers","year":"2019","unstructured":"Withers SS, York D, Choi JW et al (2019) Metastatic immune infiltrates correlate with those of the primary tumour in canine osteosarcoma. Vet Comp Oncol 17(3):242\u2013252. https:\/\/doi.org\/10.1111\/vco.12459","journal-title":"Vet Comp Oncol"},{"key":"7_CR121","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/j.1939-1676.2010.0557.x","volume":"24","author":"BJ Biller","year":"2010","unstructured":"Biller BJ, Guth A, Burton JH, Dow SW (2010) Decreased ratio of CD8+ T cells to regulatory T cells associated with decreased survival in dogs with osteosarcoma. J Vet Intern Med 24:1118\u20131123. https:\/\/doi.org\/10.1111\/j.1939-1676.2010.0557.x","journal-title":"J Vet Intern Med"},{"key":"7_CR122","doi-asserted-by":"publisher","first-page":"30093","DOI":"10.1038\/srep30093","volume":"6","author":"P Koirala","year":"2016","unstructured":"Koirala P, Roth ME, Gill J et al (2016) Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma. Sci Rep 6:30093. https:\/\/doi.org\/10.1038\/srep30093","journal-title":"Sci Rep"},{"issue":"4","key":"7_CR123","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/03008207.2018.1552267","volume":"60","author":"MX Liu","year":"2019","unstructured":"Liu MX, Liu QY, Liu Y et al (2019) Interleukin-35 suppresses antitumor activity of circulating CD8(+) T cells in osteosarcoma patients. Connect Tissue Res 60(4):367\u2013375. https:\/\/doi.org\/10.1080\/03008207.2018.1552267","journal-title":"Connect Tissue Res"},{"key":"7_CR124","doi-asserted-by":"publisher","unstructured":"Seager RJ, Hajal C, Spill F et al (2017) Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression. Converg Sci Phys Oncol 3. https:\/\/doi.org\/10.1088\/2057-1739\/AA7E86","DOI":"10.1088\/2057-1739\/AA7E86"},{"key":"7_CR125","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1101\/gad.314617.118","volume":"32","author":"H Gonzalez","year":"2018","unstructured":"Gonzalez H, Hagerling C, Werb Z (2018) Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev 32:1267\u20131284","journal-title":"Genes Dev"},{"key":"7_CR126","doi-asserted-by":"crossref","unstructured":"DeNardo DG, Coussens LM (2007) Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res 9:212","DOI":"10.1186\/bcr1746"},{"key":"7_CR127","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.molmed.2012.09.007","volume":"18","author":"F Martin","year":"2012","unstructured":"Martin F, Apetoh L, Ghiringhelli F (2012) Controversies on the role of Th17 in cancer: a TGF-\u03b2-dependent immunosuppressive activity? Trends Mol Med 18:742\u2013749","journal-title":"Trends Mol Med"},{"key":"7_CR128","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ajpath.2012.08.041","volume":"182","author":"J Ye","year":"2013","unstructured":"Ye J, Livergood RS, Peng G (2013) The role and regulation of human Th17 cells in tumor immunity. Am J Pathol 182:10\u201320","journal-title":"Am J Pathol"},{"key":"7_CR129","doi-asserted-by":"publisher","unstructured":"Sakaguchi S, Wing K, Onishi Y et al Regulatory T cells: how do they suppress immune responses? Int Immunol 21:1105\u20131111. https:\/\/doi.org\/10.1093\/intimm\/dxp095","DOI":"10.1093\/intimm\/dxp095"},{"key":"7_CR130","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12307-012-0122-y","volume":"6","author":"C Tanchot","year":"2013","unstructured":"Tanchot C, Terme M, Pere H et al (2013) Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance. Cancer Microenviron 6:147\u2013157. https:\/\/doi.org\/10.1007\/s12307-012-0122-y","journal-title":"Cancer Microenviron"},{"key":"7_CR131","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","volume":"33","author":"DS Thommen","year":"2018","unstructured":"Thommen DS, Schumacher TN (2018) T Cell Dysfunction in Cancer. Cancer Cell 33:547\u2013562","journal-title":"Cancer Cell"},{"key":"7_CR132","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1080\/02841860701233443","volume":"46","author":"S Gupta","year":"2007","unstructured":"Gupta S, Joshi K, Wig JD, Arora SK (2007) Intratumoral FOXP3 expression in infiltrating breast carcinoma: its association with clinicopathologic parameters and angiogenesis. Acta Oncol (Madr) 46:792\u2013797. https:\/\/doi.org\/10.1080\/02841860701233443","journal-title":"Acta Oncol (Madr)"},{"key":"7_CR133","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","volume":"37","author":"V Kumar","year":"2016","unstructured":"Kumar V, Patel S, Tcyganov E, Gabrilovich DI (2016) The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol 37:208\u2013220","journal-title":"Trends Immunol"},{"key":"7_CR134","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/cr.2016.151","volume":"27","author":"A Tanaka","year":"2017","unstructured":"Tanaka A, Sakaguchi S (2017) Regulatory T cells in cancer immunotherapy. Cell Res 27:109\u2013118","journal-title":"Cell Res"},{"key":"7_CR135","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","volume":"27","author":"SL Topalian","year":"2015","unstructured":"Topalian SL, Drake CG, Pardoll DM (2015) Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 27:450\u2013461","journal-title":"Cancer Cell"},{"key":"7_CR136","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","volume":"371","author":"A Snyder","year":"2014","unstructured":"Snyder A, Makarov V, Merghoub T et al (2014) Genetic basis for clinical response to CTLA-4 blockade in melanoma. N Engl J Med 371:2189\u20132199. https:\/\/doi.org\/10.1056\/NEJMoa1406498","journal-title":"N Engl J Med"},{"key":"7_CR137","doi-asserted-by":"publisher","unstructured":"B\u00f6ger C, Behrens HM, Kr\u00fcger S, R\u00f6cken C (2017) The novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1\/PD-1: a future perspective for a combined gastric cancer therapy? Oncoimmunology 6. https:\/\/doi.org\/10.1080\/2162402X.2017.1293215","DOI":"10.1080\/2162402X.2017.1293215"},{"key":"7_CR138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.2017.136","volume":"117","author":"AP Cogdill","year":"2017","unstructured":"Cogdill AP, Andrews MC, Wargo JA (2017) Hallmarks of response to immune checkpoint blockade. Br J Cancer 117:1\u20137","journal-title":"Br J Cancer"},{"key":"7_CR139","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00262-008-0583-5","volume":"58","author":"N Leffers","year":"2009","unstructured":"Leffers N, Gooden MJM, De Jong RA et al (2009) Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer. Cancer Immunol Immunother 58:449\u2013459. https:\/\/doi.org\/10.1007\/s00262-008-0583-5","journal-title":"Cancer Immunol Immunother"},{"key":"7_CR140","doi-asserted-by":"publisher","unstructured":"MI Carvalho, I Pires, J Prada, FL Queiroga (2014) A role for T-lymphocytes in human breast cancer and in canine mammary tumors. Biomed Res Int 2014. https:\/\/doi.org\/10.1155\/2014\/130894","DOI":"10.1155\/2014\/130894"},{"key":"7_CR141","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/j.1365-2559.2011.03846.x","volume":"58","author":"K Baker","year":"2011","unstructured":"Baker K, Lachapelle J, Zlobec I et al (2011) Prognostic significance of CD8+ T lymphocytes in breast cancer depends upon both oestrogen receptor status and histological grade. Histopathology 58:1107\u20131116. https:\/\/doi.org\/10.1111\/j.1365-2559.2011.03846.x","journal-title":"Histopathology"},{"key":"7_CR142","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1177\/104063879300500420","volume":"5","author":"L Ferrer","year":"1993","unstructured":"Ferrer L, Fondevila D, Rabanal R et al (1993) Immunohistochemical detection of cd3 antigen (pan T marker) in canine lymphomas. J Vet Diagnostic Investig 5:616\u2013620. https:\/\/doi.org\/10.1177\/104063879300500420","journal-title":"J Vet Diagnostic Investig"},{"issue":"80","key":"7_CR143","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon J, Costes A, Sanchez-Cabo F et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313(80):1960\u20131964. https:\/\/doi.org\/10.1126\/science.1129139","journal-title":"Science"},{"key":"7_CR144","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.clim.2009.10.005","volume":"134","author":"XL Yuan","year":"2010","unstructured":"Yuan XL, Chen L, Li MX et al (2010) Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clin Immunol 134:277\u2013288. https:\/\/doi.org\/10.1016\/j.clim.2009.10.005","journal-title":"Clin Immunol"},{"key":"7_CR145","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1038\/onc.2016.458","volume":"36","author":"X Wang","year":"2017","unstructured":"Wang X, Lang M, Zhao T et al (2017) Cancer-FOXP3 directly activated CCL5 to recruit FOXP3 + Treg cells in pancreatic ductal adenocarcinoma. Oncogene 36:3048\u20133058. https:\/\/doi.org\/10.1038\/onc.2016.458","journal-title":"Oncogene"},{"key":"7_CR146","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/j.1348-0421.2007.tb03999.x","volume":"51","author":"Y Horiuchi","year":"2007","unstructured":"Horiuchi Y, Hanazawa A, Nakajima Y et al (2007) T-helper (Th) 1\/ Th2 imbalance in the peripheral blood of dogs with malignant tumor. Microbiol Immunol 51:1135\u20131138. https:\/\/doi.org\/10.1111\/j.1348-0421.2007.tb03999.x","journal-title":"Microbiol Immunol"},{"key":"7_CR147","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1177\/0300985817690208","volume":"54","author":"A Marcinowska","year":"2017","unstructured":"Marcinowska A, Constantino-Casas F, Williams T et al (2017) T lymphocytes in histiocytic sarcomas of flat-coated retriever dogs. Vet Pathol 54:605\u2013610. https:\/\/doi.org\/10.1177\/0300985817690208","journal-title":"Vet Pathol"},{"key":"7_CR148","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman J (1971) Tumor Angiogenesis: Therapeutic Implications. N Engl J Med 285:1182\u20131186","journal-title":"N Engl J Med"},{"key":"7_CR149","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.4049\/jimmunol.172.7.4618","volume":"172","author":"F Mor","year":"2004","unstructured":"Mor F, Quintana FJ, Cohen IR (2004) Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol 172:4618\u20134623. https:\/\/doi.org\/10.4049\/jimmunol.172.7.4618","journal-title":"J Immunol"},{"key":"7_CR150","doi-asserted-by":"publisher","unstructured":"Batlle R, Andr\u00e9s E, Gonzalez L et al (2019) Regulation of tumor angiogenesis and mesenchymal\u2013endothelial transition by p38\u03b1 through TGF-\u03b2 and JNK signaling. Nat Commun 10. https:\/\/doi.org\/10.1038\/s41467-019-10946-y","DOI":"10.1038\/s41467-019-10946-y"},{"key":"7_CR151","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2147\/CMAR.S146897","volume":"9","author":"K Shimizu","year":"2017","unstructured":"Shimizu K, Okita R, Saisho S et al (2017) Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma. Cancer Manag Res 9:741\u2013750. https:\/\/doi.org\/10.2147\/CMAR.S146897","journal-title":"Cancer Manag Res"},{"key":"7_CR152","doi-asserted-by":"publisher","unstructured":"Jiang R, Tang J, Chen Y et al (2017) The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion. Nat Commun 8. https:\/\/doi.org\/10.1038\/ncomms15129","DOI":"10.1038\/ncomms15129"},{"key":"7_CR153","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s13277-012-0345-z","volume":"33","author":"V Wiwanitkit","year":"2012","unstructured":"Wiwanitkit V (2012) Combination of EGFR and COX-2 inhibitors in breast cancer patient. Tumour Biol 33:1261","journal-title":"Tumour Biol"},{"key":"7_CR154","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/carcin\/bgp014","volume":"30","author":"A Greenhough","year":"2009","unstructured":"Greenhough A, Smartt HJM, Moore AE et al (2009) The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 30:377\u2013386. https:\/\/doi.org\/10.1093\/carcin\/bgp014","journal-title":"Carcinogenesis"},{"key":"7_CR155","doi-asserted-by":"publisher","unstructured":"Markosyan N, Chen EP, Evans RA et al (2013) Mammary carcinoma cell derived cyclooxygenase 2 suppresses tumor immune surveillance by enhancing intratumoral immune checkpoint activity. Breast Cancer Res 15. https:\/\/doi.org\/10.1186\/bcr3469","DOI":"10.1186\/bcr3469"},{"key":"7_CR156","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1749-6632.2009.05122.x","volume":"1183","author":"P Ray","year":"2010","unstructured":"Ray P, Krishnamoorthy N, Oriss TB, Ray A (2010) Signaling of c-kit in dendritic cells influences adaptive immunity. Ann N Y Acad Sci 1183:104\u2013122","journal-title":"Ann N Y Acad Sci"},{"key":"7_CR157","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/ACI.0000000000000019","volume":"14","author":"TB Oriss","year":"2014","unstructured":"Oriss TB, Krishnamoorthy N, Ray P, Ray A (2014) Dendritic cell c-kit signaling and adaptive immunity: implications for the upper airways. Curr Opin Allergy Clin Immunol 14:7\u201312","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"7_CR158","doi-asserted-by":"publisher","first-page":"435","DOI":"10.7150\/ijbs.6087","volume":"9","author":"J Liang","year":"2013","unstructured":"Liang J, Wu YL, Chen BJ et al (2013) The C-Kit receptor-mediated signal transduction and tumor-related diseases. Int J Biol Sci 9:435\u2013443","journal-title":"Int J Biol Sci"},{"key":"7_CR159","doi-asserted-by":"publisher","unstructured":"Carvalho MI, Silva-Carvalho R, Pires I et al (2016) A comparative approach of tumor-associated inflammation in mammary cancer between humans and dogs. Biomed Res Int 2016. https:\/\/doi.org\/10.1155\/2016\/4917387","DOI":"10.1155\/2016\/4917387"},{"key":"7_CR160","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.cell.2006.01.007","volume":"124","author":"J Condeelis","year":"2006","unstructured":"Condeelis J, Pollard JW (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124:263\u2013266","journal-title":"Cell"},{"key":"7_CR161","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2009.06.018","volume":"16","author":"DG DeNardo","year":"2009","unstructured":"DeNardo DG, Barreto JB, Andreu P et al (2009) CD4+ T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16:91\u2013102. https:\/\/doi.org\/10.1016\/j.ccr.2009.06.018","journal-title":"Cancer Cell"},{"key":"7_CR162","doi-asserted-by":"publisher","unstructured":"Juric V, O\u2019Sullivan C, Stefanutti E et al (2018) MMP-9 inhibition promotes anti-tumor immunity through disruption of biochemical and physical barriers to T-cell trafficking to tumors. PLoS One 13. https:\/\/doi.org\/10.1371\/journal.pone.0207255","DOI":"10.1371\/journal.pone.0207255"},{"key":"7_CR163","doi-asserted-by":"crossref","unstructured":"Marin-Acevedo JA, Soyano AE, Dholaria B et al (2018) Cancer immunotherapy beyond immune checkpoint inhibitors. J Hematol Oncol 11:8","DOI":"10.1186\/s13045-017-0552-6"},{"key":"7_CR164","doi-asserted-by":"crossref","unstructured":"Addissie S, Klingemann H (2018) Cellular immunotherapy of canine cancer. Vet Sci 5","DOI":"10.3390\/vetsci5040100"},{"key":"7_CR165","doi-asserted-by":"publisher","unstructured":"Shang B, Liu Y, Jiang SJ, Liu Y (2015) Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis. Sci Rep 5. https:\/\/doi.org\/10.1038\/srep15179","DOI":"10.1038\/srep15179"},{"key":"7_CR166","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.trecan.2017.06.005","volume":"3","author":"H Wang","year":"2017","unstructured":"Wang H, Franco F, Ho PC (2017) Metabolic regulation of Tregs in cancer: opportunities for immunotherapy. Trends in Cancer 3:583\u2013592","journal-title":"Trends in Cancer"},{"key":"7_CR167","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/imm.13058","volume":"157","author":"MA Moreno Ayala","year":"2019","unstructured":"Moreno Ayala MA, Li Z, DuPage M (2019) Treg programming and therapeutic reprogramming in cancer. Immunology 157:198\u2013209","journal-title":"Immunology"},{"key":"7_CR168","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ceb.2006.10.005","volume":"18","author":"RJ Shaw","year":"2006","unstructured":"Shaw RJ (2006) Glucose metabolism and cancer. Curr Opin Cell Biol 18:598\u2013608","journal-title":"Curr Opin Cell Biol"},{"key":"7_CR169","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4:891\u2013899","journal-title":"Nat Rev Cancer"},{"key":"7_CR170","doi-asserted-by":"crossref","unstructured":"Kim HH, Joo H, Kim T, et al (2009) The mitochondrial Warburg effect: a cancer enigma. IBC, 1(2):7, 1\u20137. https:\/\/doi.org\/10.4051\/ibc.2009.2.0007","DOI":"10.4051\/ibc.2009.2.0007"},{"key":"7_CR171","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrd3504","volume":"10","author":"MG Vander Heiden","year":"2011","unstructured":"Vander Heiden MG (2011) Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov 10:671\u2013684","journal-title":"Nat Rev Drug Discov"},{"key":"7_CR172","doi-asserted-by":"crossref","unstructured":"Gillies RJ, Robey I, Gatenby RA (2008) Causes and consequences of increased glucose metabolism of cancers. J Nucl Med 49:24S\u201342S","DOI":"10.2967\/jnumed.107.047258"},{"key":"7_CR173","doi-asserted-by":"publisher","unstructured":"de Saedeleer CJ, Copetti T, Porporato PE et al (2012) Lactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cells. PLoS One 7. https:\/\/doi.org\/10.1371\/journal.pone.0046571","DOI":"10.1371\/journal.pone.0046571"},{"issue":"80","key":"7_CR174","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MGV Heiden","year":"2009","unstructured":"Heiden MGV, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(80):1029\u20131033","journal-title":"Science"},{"key":"7_CR175","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pharmthera.2008.09.005","volume":"121","author":"V Ganapathy","year":"2009","unstructured":"Ganapathy V, Thangaraju M, Prasad PD (2009) Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther 121:29\u201340","journal-title":"Pharmacol Ther"},{"key":"7_CR176","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1002\/cmdc.201200176","volume":"7","author":"C Granchi","year":"2012","unstructured":"Granchi C, Minutolo F (2012) Anticancer agents that counteract tumor glycolysis. ChemMedChem 7:1318\u20131350. https:\/\/doi.org\/10.1002\/cmdc.201200176","journal-title":"ChemMedChem"},{"key":"7_CR177","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1172\/JCI36843","volume":"118","author":"P Sonveaux","year":"2008","unstructured":"Sonveaux P, V\u00e9gran F, Schroeder T et al (2008) Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 118:3930\u20133942. https:\/\/doi.org\/10.1172\/JCI36843","journal-title":"J Clin Invest"},{"key":"7_CR178","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrc2468","volume":"8","author":"NC Denko","year":"2008","unstructured":"Denko NC (2008) Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 8:705\u2013713","journal-title":"Nat Rev Cancer"},{"key":"7_CR179","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/onc.2013.121","volume":"33","author":"A Casazza","year":"2014","unstructured":"Casazza A, Di Conza G, Wenes M et al (2014) Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment. Oncogene 33:1743\u20131754","journal-title":"Oncogene"},{"key":"7_CR180","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1254\/jphs.10R25FM","volume":"115","author":"H Nagasawa","year":"2011","unstructured":"Nagasawa H (2011) Pathophysiological response to hypoxia \u2013 from the molecular mechanisms of malady to drug discovery: drug discovery for targeting the tumor microenvironment. J Pharmacol Sci 115:446\u2013452","journal-title":"J Pharmacol Sci"},{"key":"7_CR181","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10863-012-9428-1","volume":"44","author":"C Pinheiro","year":"2012","unstructured":"Pinheiro C, Longatto-Filho A, Azevedo-Silva J et al (2012) Role of monocarboxylate transporters in human cancers: state of the art. J Bioenerg Biomembr 44:127\u2013139","journal-title":"J Bioenerg Biomembr"},{"key":"7_CR182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00018.2019","volume":"100","author":"C Riera-Domingo","year":"2020","unstructured":"Riera-Domingo C, Audig\u00e9 A, Granja S et al (2020) Immunity, hypoxia, and metabolism\u2013the m\u00e9nage \u00e0 trois of cancer: implications for immunotherapy. Physiol Rev 100:1\u2013102. https:\/\/doi.org\/10.1152\/physrev.00018.2019","journal-title":"Physiol Rev"},{"key":"7_CR183","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.immuni.2014.09.008","volume":"41","author":"A Palazon","year":"2014","unstructured":"Palazon A, Goldrath AW, Nizet V, Johnson RS (2014) HIF transcription factors, inflammation, and immunity. Immunity 41:518\u2013528","journal-title":"Immunity"},{"key":"7_CR184","doi-asserted-by":"publisher","first-page":"6921","DOI":"10.1158\/0008-5472.CAN-11-1457","volume":"71","author":"F Hirschhaeuser","year":"2011","unstructured":"Hirschhaeuser F, Sattler UGA, Mueller-Klieser W (2011) Lactate: A metabolic key player in cancer. Cancer Res 71:6921\u20136925","journal-title":"Cancer Res"},{"key":"7_CR185","doi-asserted-by":"crossref","unstructured":"Morrot A, da Fonseca LM, Salustiano EJ et al (2018) Metabolic symbiosis and immunomodulation: How tumor cell-derived lactate may disturb innate and adaptive immune responses. Front Oncol 8:81","DOI":"10.3389\/fonc.2018.00081"},{"key":"7_CR186","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2217\/fon.09.145","volume":"6","author":"KM Kennedy","year":"2010","unstructured":"Kennedy KM, Dewhirst MW (2010) Tumor metabolism of lactate: The influence and therapeutic potential for MCT and CD147 regulation. Future Oncol 6:127\u2013148","journal-title":"Future Oncol"},{"key":"7_CR187","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1292\/jvms.69.599","volume":"69","author":"Y Shimoyama","year":"2007","unstructured":"Shimoyama Y, Kirat D, Akihara Y et al (2007) Expression of monocarboxylate transporter 1 (MCT1) in the dog intestine. J Vet Med Sci 69:599\u2013604. https:\/\/doi.org\/10.1292\/jvms.69.599","journal-title":"J Vet Med Sci"},{"key":"7_CR188","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1354\/vp.44-4-449","volume":"44","author":"Y Shimoyama","year":"2007","unstructured":"Shimoyama Y, Akihara Y, Kirat D et al (2007) Expression of monocarboxylate transporter 1 in oral and ocular canine melanocytic tumors. Vet Pathol 44:449\u2013457. https:\/\/doi.org\/10.1354\/vp.44-4-449","journal-title":"Vet Pathol"},{"key":"7_CR189","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.semradonc.2004.04.004","volume":"14","author":"S Walenta","year":"2004","unstructured":"Walenta S, Mueller-Klieser WF (2004) Lactate: Mirror and motor of tumor malignancy. Semin Radiat Oncol 14:267\u2013274. https:\/\/doi.org\/10.1016\/j.semradonc.2004.04.004","journal-title":"Semin Radiat Oncol"},{"key":"7_CR190","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00262-010-0967-1","volume":"60","author":"K Singer","year":"2011","unstructured":"Singer K, Gottfried E, Kreutz M, Mackensen A (2011) Suppression of T-cell responses by tumor metabolites. Cancer Immunol Immunother 60:425\u2013431","journal-title":"Cancer Immunol Immunother"},{"key":"7_CR191","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","volume":"109","author":"K Fischer","year":"2007","unstructured":"Fischer K, Hoffmann P, Voelkl S et al (2007) Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109:3812\u20133819. https:\/\/doi.org\/10.1182\/blood-2006-07-035972","journal-title":"Blood"},{"key":"7_CR192","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1002\/ijc.25543","volume":"128","author":"K Singer","year":"2011","unstructured":"Singer K, Kastenberger M, Gottfried E et al (2011) Warburg phenotype in renal cell carcinoma: high expression of glucose-transporter 1 (GLUT-1) correlates with low CD8+ T-cell infiltration in the tumor. Int J Cancer 128:2085\u20132095. https:\/\/doi.org\/10.1002\/ijc.25543","journal-title":"Int J Cancer"},{"key":"7_CR193","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/ijc.26410","volume":"131","author":"AN Mendler","year":"2012","unstructured":"Mendler AN, Hu B, Prinz PU et al (2012) Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK\/c-Jun activation. Int J Cancer 131:633\u2013640. https:\/\/doi.org\/10.1002\/ijc.26410","journal-title":"Int J Cancer"},{"key":"7_CR194","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","volume":"186","author":"RD Michalek","year":"2011","unstructured":"Michalek RD, Gerriets VA, Jacobs SR et al (2011) Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4 + T cell subsets. J Immunol 186:3299\u20133303. https:\/\/doi.org\/10.4049\/jimmunol.1003613","journal-title":"J Immunol"},{"key":"7_CR195","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1182\/blood-2005-05-1795","volume":"107","author":"E Gottfried","year":"2006","unstructured":"Gottfried E, Kunz-Schughart LA, Ebner S et al (2006) Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood 107:2013\u20132021. https:\/\/doi.org\/10.1182\/blood-2005-05-1795","journal-title":"Blood"},{"key":"7_CR196","doi-asserted-by":"publisher","first-page":"7175","DOI":"10.4049\/jimmunol.180.11.7175","volume":"180","author":"H Shime","year":"2008","unstructured":"Shime H, Yabu M, Akazawa T et al (2008) Tumor-secreted lactic acid promotes IL-23\/IL-17 proinflammatory pathway. J Immunol 180:7175\u20137183. https:\/\/doi.org\/10.4049\/jimmunol.180.11.7175","journal-title":"J Immunol"},{"key":"7_CR197","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature04808","volume":"442","author":"JL Langowski","year":"2006","unstructured":"Langowski JL, Zhang X, Wu L et al (2006) IL-23 promotes tumour incidence and growth. Nature 442:461\u2013465. https:\/\/doi.org\/10.1038\/nature04808","journal-title":"Nature"},{"key":"7_CR198","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.4049\/jimmunol.0902584","volume":"184","author":"K Dietl","year":"2010","unstructured":"Dietl K, Renner K, Dettmer K et al (2010) Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes. J Immunol 184:1200\u20131209. https:\/\/doi.org\/10.4049\/jimmunol.0902584","journal-title":"J Immunol"},{"key":"7_CR199","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3892\/ijo.2011.1055","volume":"39","author":"K Goetze","year":"2011","unstructured":"Goetze K, Walenta S, Ksiazkiewicz M et al (2011) Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release. Int J Oncol 39:453\u2013463. https:\/\/doi.org\/10.3892\/ijo.2011.1055","journal-title":"Int J Oncol"},{"key":"7_CR200","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio OR, Chu NQ, Szabo AL et al (2014) Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513:559\u2013563. https:\/\/doi.org\/10.1038\/nature13490","journal-title":"Nature"},{"key":"7_CR201","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.4049\/jimmunol.1202702","volume":"191","author":"Z Husain","year":"2013","unstructured":"Husain Z, Huang Y, Seth P, Sukhatme VP (2013) Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells. J Immunol 191:1486\u20131495. https:\/\/doi.org\/10.4049\/jimmunol.1202702","journal-title":"J Immunol"},{"key":"7_CR202","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/cells8020104","volume":"8","author":"C Domblides","year":"2019","unstructured":"Domblides C, Lartigue L, Faustin B (2019) Control of the antitumor immune response by cancer metabolism. Cell 8:104. https:\/\/doi.org\/10.3390\/cells8020104","journal-title":"Cell"},{"key":"7_CR203","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.gde.2004.12.002","volume":"15","author":"E Sahai","year":"2005","unstructured":"Sahai E (2005) Mechanisms of cancer cell invasion. Curr Opin Genet Dev 15:87\u201396","journal-title":"Curr Opin Genet Dev"},{"key":"7_CR204","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ceb.2005.08.002","volume":"17","author":"H Yamaguchi","year":"2005","unstructured":"Yamaguchi H, Wyckoff J, Condeelis J (2005) Cell migration in tumors. Curr Opin Cell Biol 17:559\u2013564","journal-title":"Curr Opin Cell Biol"},{"key":"7_CR205","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.tcb.2018.04.002","volume":"28","author":"I Elia","year":"2018","unstructured":"Elia I, Doglioni G, Fendt SM (2018) Metabolic hallmarks of metastasis formation. Trends Cell Biol 28:673\u2013684","journal-title":"Trends Cell Biol"},{"key":"7_CR206","doi-asserted-by":"crossref","unstructured":"de la Cruz-L\u00f3pez KG, Castro-Mu\u00f1oz LJ, Reyes-Hern\u00e1ndez DO et al (2019) Lactate in the regulation of tumor microenvironment and therapeutic approaches. Front Oncol 9:1143","DOI":"10.3389\/fonc.2019.01143"},{"key":"7_CR207","doi-asserted-by":"publisher","first-page":"56081","DOI":"10.18632\/oncotarget.9760","volume":"8","author":"M Anderson","year":"2017","unstructured":"Anderson M, Marayati R, Moffitt R, Yeh JJ (2017) Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer. Oncotarget 8:56081\u201356094. https:\/\/doi.org\/10.18632\/oncotarget.9760","journal-title":"Oncotarget"},{"key":"7_CR208","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/bjc.2016.26","volume":"114","author":"LE Botzer","year":"2016","unstructured":"Botzer LE, Maman S, Sagi-Assif O et al (2016) Hexokinase 2 is a determinant of neuroblastoma metastasis. Br J Cancer 114:759\u2013766. https:\/\/doi.org\/10.1038\/bjc.2016.26","journal-title":"Br J Cancer"},{"key":"7_CR209","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.clinre.2019.06.008","volume":"44","author":"Z Qian","year":"2020","unstructured":"Qian Z, Hu W, Lv Z et al (2020) PKM2 upregulation promotes malignancy and indicates poor prognosis for intrahepatic cholangiocarcinoma. Clin Res Hepatol Gastroenterol 44:162\u2013173. https:\/\/doi.org\/10.1016\/j.clinre.2019.06.008","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"7_CR210","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/iub.1066","volume":"64","author":"CF Zhou","year":"2012","unstructured":"Zhou CF, Li XB, Sun H et al (2012) Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells. IUBMB Life 64:775\u2013782. https:\/\/doi.org\/10.1002\/iub.1066","journal-title":"IUBMB Life"},{"key":"7_CR211","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.4161\/cc.9.17.12731","volume":"9","author":"G Bonuccelli","year":"2010","unstructured":"Bonuccelli G, Tsirigos A, Whitaker-Menezes D et al (2010) Ketones and lactate \u201cfuel\u201d tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 9:3506\u20133514. https:\/\/doi.org\/10.4161\/cc.9.17.12731","journal-title":"Cell Cycle"},{"key":"7_CR212","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00018-015-2098-5","volume":"73","author":"VL Payen","year":"2016","unstructured":"Payen VL, Porporato PE, Baselet B, Sonveaux P (2016) Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway. Cell Mol Life Sci 73:1333\u20131348","journal-title":"Cell Mol Life Sci"},{"key":"7_CR213","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3233\/CBM-150514","volume":"15","author":"PJ Vlachostergios","year":"2015","unstructured":"Vlachostergios PJ, Oikonomou KG, Gibilaro E, Apergis G (2015) Elevated lactic acid is a negative prognostic factor in metastatic lung cancer. Cancer Biomark 15:725\u2013734. https:\/\/doi.org\/10.3233\/CBM-150514","journal-title":"Cancer Biomark"},{"key":"7_CR214","first-page":"4757","volume":"55","author":"S Walenta","year":"2000","unstructured":"Walenta S, Wetterling M, Lehrke M et al (2000) Cancer Research. Cancer Res 55:4757\u20134759","journal-title":"Cancer Res"},{"key":"7_CR215","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0360-3016(01)01630-3","volume":"51","author":"DM Brizel","year":"2001","unstructured":"Brizel DM, Schroeder T, Scher RL et al (2001) Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 51:349\u2013353. https:\/\/doi.org\/10.1016\/S0360-3016(01)01630-3","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Advances in Experimental Medicine and Biology","Tumor Microenvironment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-73119-9_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T23:15:21Z","timestamp":1675811721000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-73119-9_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030731182","9783030731199"],"references-count":215,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-73119-9_7","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"19 October 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}